ISRA VanEck Vectors Israel ETF
- 35.939
- -0.104-0.29%
Express News | President Biden Says Palestinians Have Endured Sheer Hell, Too Many Civilians Killed; "It's Time For The War To End"
Express News | President Biden Says A Comprehensive Approach Like This Will Lead To A More Secure Israel; U.S. Will Help Forge A Resolution On Lebanon Border; This Deal Can Help Israel Become More Integrated Into The Region, Including With Saudi Arabia; A Better...
Express News | Biden Says I Know Some In Israel Will Not Agree With This Plan, Including Some In Government; I Urge Israeli Leadership To Back This Deal Despite Any Pressure; I Ask Israelis To Take A Step Back And Think What Happens If This Moment Is Lost; Risk Of...
Express News | President Biden Says If Negotiations Take More Than 6-Weeks, Ceasefire Will Continue As Long As Talks Continue; Phase Two Will Be An Exchange For The Release Of All Remaining Living Hostages And Israeli Forces Will Withdraw; In Phase Three, There Will...
Express News | President Biden Says Israel Has Offered A Comprehensive New Proposal; New Proposal Has 3 Phases; First Phase Will Last 6-Weeks With A Complete Ceasefire And Withdrawal Of Israel Forces From Populated Areas Of Gaza; Palestinians Would Return To Their...
4 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know
In the latest quarter, 4 analysts provided ratings for Teva Pharmaceutical Indus (NYSE:TEVA), showcasing a mix of bullish and bearish perspectives.The following table encapsulates their recent ratings
Teva Pharmaceutical Indus Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/30/2024 25.9% B of A Securities $18 → $21 Maintains Buy 05/13/2024 19.9% Piper Sandler $19 → $20 Reiter
Express News | 'Israeli War Cabinet Minister Benny Gantz's Centrist Party Has Proposed Holding A Vote To Dissolve Parliament In A Bid To Bring About An Early Election, His Party Said In A Statement On Thursday' - Reuters News
Teva Wins FDA Nod for New Austedo Formulation
Reported Earlier, Teva's AUSTEDO XR Receives FDA Green Light, One Pill, Once-Daily Dosage Now Available For TD And HD Chorea
U.S. FDA approves new one pill, once-daily AUSTEDO XR tablets (30, 36, 42, 48 mg/day)AUSTEDO XR offers more flexibility with the most once-daily doses of any vesicular monoamine transporter 2 (VMAT2)
Express News | One Child Killed, Dozens Injured In Israeli Attack On Syria's Baniyas
Allot Taps Liat Nahum of Amdocs Ltd as CFO, Effective July 1
Allot Ltd. (NASDAQ:ALLT, TASE: ALLT))))), a leading global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide, today announced the appoi
Express News | 'Israel Gave Mediators Updated Proposal for Gaza Hostage-ceasefire Deal' - Axios
Express News | Israel Finance Minister Smotrich Responds To World Court Ruling, Says Demanding Israel Stop The War Is Asking It To Cease To Exist; Israel Will Not Agree To That
Top 5 Tech Stocks That Could Lead To Your Biggest Gains This Month
The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when
CyberArk Software Investor Event Highlights Partnerships, Financial Strength: Baird
Teva Pharmaceutical Indus's Options Frenzy: What You Need to Know
Investors with a lot of money to spend have taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA).And retail traders should know.We noticed this today when the positions showed up on publicl
Usercentrics, Wix Partner To Launch Consent Solution On The Wix App Market
Usercentrics, data privacy solutions leader managing over 5.2 billion monthly consents across platforms, partners with Wix, Wix.com Ltd. (NASDAQ:WIX), the leading SaaS website builder platform to crea
Wix.com Analysts Boost Their Forecasts Following Q1 Results
Wix.com Ltd (NASDAQ:WIX) reported better-than-expected sales for its fiscal first quarter 2024 on Monday.Revenue grew 12% Y/Y to $419.8 million, beating the analyst consensus estimate of $417.8 millio
Palo Alto Networks To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Stifel boos